These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 23255761

  • 1. Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 1, Normal findings.
    Sainani NI, Gervais DA, Mueller PR, Arellano RS.
    AJR Am J Roentgenol; 2013 Jan; 200(1):184-93. PubMed ID: 23255761
    [Abstract] [Full Text] [Related]

  • 2. Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 2, Abnormal findings.
    Sainani NI, Gervais DA, Mueller PR, Arellano RS.
    AJR Am J Roentgenol; 2013 Jan; 200(1):194-204. PubMed ID: 23255762
    [Abstract] [Full Text] [Related]

  • 3. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome.
    Dodd GD, Napier D, Schoolfield JD, Hubbard L.
    AJR Am J Roentgenol; 2005 Jul; 185(1):51-7. PubMed ID: 15972398
    [Abstract] [Full Text] [Related]

  • 4. Radiofrequency ablation of the liver: how do we do it.
    Vandenbroucke F, Ilsen B, Craggs B, Op de Beeck B, de Mey J.
    JBR-BTR; 2007 Jul; 90(6):490-1. PubMed ID: 18376762
    [Abstract] [Full Text] [Related]

  • 5. Radiofrequency ablation of liver cancer.
    Lencioni R, Crocetti L.
    Tech Vasc Interv Radiol; 2007 Mar; 10(1):38-46. PubMed ID: 17980317
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis and treatment of intrahepatic biloma complicating radiofrequency ablation of hepatic metastases.
    Shankar S, vanSonnenberg E, Silverman SG, Tuncali K, Morrison PR.
    AJR Am J Roentgenol; 2003 Aug; 181(2):475-7. PubMed ID: 12876029
    [No Abstract] [Full Text] [Related]

  • 7. Image fusion as a new postprocessing method to evaluate the radiofrequency ablation zone after treatment of malignant liver tumors.
    Iyer RS, Timm BA, Mitsumori LM, Kolokythas O.
    J Comput Assist Tomogr; 2010 Aug; 34(2):226-8. PubMed ID: 20351510
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. How to report and compare complications of image-guided ablation therapies: comments on seeding and the use of a sole common denominator for liver tumors.
    Arienti V, Pretolani S, Goldberg SN, Silverman SG, Gervais DA, Lencioni R, Sacks D, Dupuy D.
    Radiology; 2006 Nov; 241(2):625-6; author reply 626-7. PubMed ID: 17057081
    [No Abstract] [Full Text] [Related]

  • 13. Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis.
    Kondo Y, Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Goto E, Nakagawa H, Masuzaki R, Asaoka Y, Fujie H, Goto T, Omata M, Yoshida H, Koike K.
    Liver Int; 2011 Feb; 31(2):197-205. PubMed ID: 21159122
    [Abstract] [Full Text] [Related]

  • 14. Magnetic resonance guidance for radiofrequency ablation of liver tumors.
    Clasen S, Pereira PL.
    J Magn Reson Imaging; 2008 Feb; 27(2):421-33. PubMed ID: 18219677
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Radiofrequency ablation for the management of liver tumors.
    Bachar GN, Greif F, Mor E, Tur-Kaspa R, Belenky A.
    Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
    Frieser M, Kiesel J, Lindner A, Bernatik T, Haensler JM, Janka R, Hahn EG, Strobel D.
    Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
    [Abstract] [Full Text] [Related]

  • 19. Percutaneous radiofrequency ablation of hepatocellular carcinomas: factors related to intraprocedural and postprocedural pain.
    Lee S, Rhim H, Kim YS, Choi D, Lee WJ, Lim HK, Shin B.
    AJR Am J Roentgenol; 2009 Apr; 192(4):1064-70. PubMed ID: 19304715
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.